Literature DB >> 25681455

Anti-MOG antibodies with longitudinally extensive transverse myelitis preceded by CLIPPERS.

Mkael Symmonds1, Patrick J Waters2, Wilhelm Küker2, M Isabel Leite2, Ursula G Schulz2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25681455      PMCID： PMC4371412          DOI： 10.1212/WNL.0000000000001370

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  7 in total

1.  Long-term outcomes of CLIPPERS (chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids) in a consecutive series of 12 patients.

Authors:  Guillaume Taieb; Claire Duflos; Dimitri Renard; Bertrand Audoin; Elsa Kaphan; Jean Pelletier; Nadège Limousin; Christine Tranchant; Stephane Kremer; Jérome de Sèze; Romain Lefaucheur; David Maltête; David Brassat; Michel Clanet; Patrice Desbordes; Eric Thouvenot; Laurent Magy; Thierry Vincent; Jean-Luc Faillie; Nicolas de Champfleur; Giovanni Castelnovo; Sandrine Eimer; Dominique Figarella Branger; Emmanuelle Uro-Coste; Pierre Labauge
Journal:  Arch Neurol       Date:  2012-07

Review 2.  CLIPPERS: chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids. Review of an increasingly recognized entity within the spectrum of inflammatory central nervous system disorders.

Authors:  A Dudesek; F Rimmele; S Tesar; S Kolbaske; P S Rommer; R Benecke; U K Zettl
Journal:  Clin Exp Immunol       Date:  2014-03       Impact factor: 4.330

3.  Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.

Authors:  Douglas Kazutoshi Sato; Dagoberto Callegaro; Marco Aurelio Lana-Peixoto; Patrick J Waters; Frederico M de Haidar Jorge; Toshiyuki Takahashi; Ichiro Nakashima; Samira Luisa Apostolos-Pereira; Natalia Talim; Renata Faria Simm; Angelina Maria Martins Lino; Tatsuro Misu; Maria Isabel Leite; Masashi Aoki; Kazuo Fujihara
Journal:  Neurology       Date:  2014-01-10       Impact factor: 9.910

Review 4.  Expanding the clinical, radiological and neuropathological phenotype of chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS).

Authors:  Neil G Simon; John D Parratt; Michael H Barnett; Michael E Buckland; Ruta Gupta; Michael W Hayes; Lynette T Masters; Stephen W Reddel
Journal:  J Neurol Neurosurg Psychiatry       Date:  2011-11-05       Impact factor: 10.154

Review 5.  The spectrum of MOG autoantibody-associated demyelinating diseases.

Authors:  Markus Reindl; Franziska Di Pauli; Kevin Rostásy; Thomas Berger
Journal:  Nat Rev Neurol       Date:  2013-06-25       Impact factor: 42.937

6.  Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS).

Authors:  Sean J Pittock; Jan Debruyne; Karl N Krecke; Caterina Giannini; Jelle van den Ameele; Veerle De Herdt; Andrew McKeon; Robert D Fealey; Brian G Weinshenker; Allen J Aksamit; Bruce R Krueger; Elizabeth A Shuster; B Mark Keegan
Journal:  Brain       Date:  2010-07-17       Impact factor: 13.501

7.  Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.

Authors:  Joanna Kitley; Patrick Waters; Mark Woodhall; M Isabel Leite; Andrew Murchison; Jithin George; Wilhelm Küker; Saleel Chandratre; Angela Vincent; Jacqueline Palace
Journal:  JAMA Neurol       Date:  2014-03       Impact factor: 18.302
  7 in total
  14 in total

Review 1.  Atypical Pediatric Demyelinating Diseases of the Central Nervous System.

Authors:  Regina M Troxell; Alison Christy
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-26       Impact factor: 5.081

Review 2.  Therapeutic Approaches in CLIPPERS.

Authors:  Guillaume Taieb; Thibaut Allou; Pierre Labauge
Journal:  Curr Treat Options Neurol       Date:  2017-05       Impact factor: 3.598

3.  MRI Patterns in Pediatric CNS Hemophagocytic Lymphohistiocytosis.

Authors:  P Malik; L Antonini; P Mannam; F N Aboobacker; A Merve; K Gilmour; K Rao; S Kumar; S E Mani; D Eleftheriou; A Rao; C Hemingway; S V Sudhakar; J Bartram; K Mankad
Journal:  AJNR Am J Neuroradiol       Date:  2021-10-07       Impact factor: 3.825

Review 4.  Myelin Oligodendrocyte Glycoprotein-Associated Disorders.

Authors:  Erin Longbrake
Journal:  Continuum (Minneap Minn)       Date:  2022-08-01

Review 5.  CLIPPERS.

Authors:  Nicholas L Zalewski; W Oliver Tobin
Journal:  Curr Neurol Neurosci Rep       Date:  2017-09       Impact factor: 5.081

Review 6.  Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) after treatment for Hodgkin's lymphoma.

Authors:  Kyoko Mashima; Shigeaki Suzuki; Takehiko Mori; Toshihiko Shimizu; Satoshi Yamada; Shigemichi Hirose; Shinichiro Okamoto; Norihiro Suzuki
Journal:  Int J Hematol       Date:  2015-08-05       Impact factor: 2.490

Review 7.  Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases.

Authors:  Patrick Peschl; Monika Bradl; Romana Höftberger; Thomas Berger; Markus Reindl
Journal:  Front Immunol       Date:  2017-05-08       Impact factor: 7.561

8.  Chronic Lymphocytic Inflammation with Pontine Perivascular Enhancement Responsive to Steroids (CLIPPERS) with Limbic Encephalitis.

Authors:  Yasuyuki Ohta; Emi Nomura; Keiichiro Tsunoda; Toru Yamashita; Yoshiaki Takahashi; Kota Sato; Mami Takemoto; Nozomi Hishikawa; Koji Abe
Journal:  Intern Med       Date:  2017-08-21       Impact factor: 1.271

9.  Expanding the MOG phenotype: Brainstem encephalitis with punctate and curvilinear enhancement.

Authors:  Susan Matesanz; Chelsea Kotch; Christopher Perrone; Angela J Waanders; Brook Hill; Sona Narula
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-09-13

10.  Parotid carcinoma following chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids: a case report.

Authors:  Yilun Deng; Bi Zhao; Bing Wei; Shihong Zhang; Ming Liu
Journal:  BMC Neurol       Date:  2021-03-10       Impact factor: 2.474
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.